LEADER 05396nam 22006375 450 001 9910300068803321 005 20251117071622.0 010 $a1-4614-9143-6 024 7 $a10.1007/978-1-4614-9143-9 035 $a(CKB)3710000000073729 035 $a(EBL)1592041 035 $a(SSID)ssj0001067638 035 $a(PQKBManifestationID)11602593 035 $a(PQKBTitleCode)TC0001067638 035 $a(PQKBWorkID)11091527 035 $a(PQKB)11785791 035 $a(MiAaPQ)EBC1592041 035 $a(DE-He213)978-1-4614-9143-9 035 $a(PPN)176100679 035 $a(EXLCZ)993710000000073729 100 $a20131121d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aLiving Donor Advocacy $eAn Evolving Role Within Transplantation /$fedited by JENNIFER STEEL 205 $a1st ed. 2014. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014. 215 $a1 online resource (357 p.) 300 $aDescription based upon print version of record. 311 08$a1-4614-9142-8 327 $aPart I: Living Donation: Chapter 1: The Medical Selection of Live Donors,- Chapter 2: Kidney Paired Donation Programs for Incompatible Living Kidney Donors and Recipients -- Chapter 3: Living Donor Liver Transplantation -- Chapter 4: Intestinal Transplantation from Living Donors -- Chapter 5: Living Donor Lung Transplantation -- Chapter 6: Live Donor Pancreas Transplantation -- Part II: Living Donor Advocacy: Chapter 7: The History of Living Donor Advocacy in Living Donor Transplantation -- Chapter 8: Findings from a National Survey of Living Donor Advocates -- Chapter 9: The Independent Donor Advocate and the Independent Donor Advocate Team -- Chapter 10: Classification of Living Organ Donors -- Chapter 11: Unrelated Donors -- Chapter 12: Education of the Donor by the ILDA (Psychosocial Aspects) -- Chapter 13: Components and Timing of the ILDA Evaluation -- Chapter 14: Contraindications to Living Donation from an ILDA Perspective -- Chapter 15: Management of Conflict Between the Independent Living Donor Advocate and the Transplant Team -- Chapter 16: Story Behind the Story -- Chapter 17: Living Donor Experience -- Part III: Living Donor Ethics: Chapter 18: Informed Consent for Living Organ Donation -- Chapter 19: Pressure and Coercion -- Chapter 20: Financial Considerations -- Chapter 21: Autonomy, Agency, and Responsibility: Ethical Concerns for Living Donor Advocates -- Chapter 22: A Practical Guide: Role of the Independent Living Donor Advocate: Protect or Advocate or Is It Both/And? -- Chapter 23: Racial Disparities in Kidney Transplant and Living Donation -- Chapter 24: The Evolution of the Role of the Independent Living Donor Advocates: Recommendations for Practice Guidelines. 330 $a  The inadequate supply of organs in the United States and other countries continues to drive the reliance on living donor transplantation.  Representatives of the transplant community convened for a meeting on living donation in an effort to provide guidelines to promote the welfare of living donors.  The consensus statement that resulted from this meeting recommended that transplant centers retain an Independent Living Donor Advocate (ILDA) to focus on the best interest of the donor.  Over a decade later, nearly every transplant center in the United States, performing living donor surgeries, has incorporated an ILDA into their living donor screening and/or evaluation process, however there are no guidelines with regard to the ILDA?s qualifications, clinical practice, or how address ethical challenges.      Living Donor Advocacy is an overview of living donation and its risks, ethical challenges and future directions regarding this role within the transplantation process.  This book provides health care professionals or consumers of health care with information that facilitates their understanding of the complexity of the living donor surgeries and medical contraindications, evaluation of the donor, and bioethics involved in living donation.    Living Donor Advocacy brings the fragmented information in the literature together into a single, invaluable resource for health professionals and those undergoing transplantation or living donor surgery. 606 $aTransplantation of organs, tissues, etc 606 $aMedicine 606 $aNephrology 606 $aHepatology 606 $aTransplant Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59117 606 $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007 606 $aNephrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33126 606 $aHepatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33088 615 0$aTransplantation of organs, tissues, etc. 615 0$aMedicine. 615 0$aNephrology. 615 0$aHepatology. 615 14$aTransplant Surgery. 615 24$aMedicine/Public Health, general. 615 24$aNephrology. 615 24$aHepatology. 676 $a362.19795 702 $aSteel$b Jennifer$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300068803321 996 $aLiving Donor Advocacy$91521867 997 $aUNINA